Harnessing the Microbiome for a Better Future: Probiotics Storm the Infant Formula Market

March 06, 2015 | State of the Market Report

Despite “breast is best” campaigns and rising breastfeeding rates, the $20.5 billion global infant formula market is here to stay, with approximately 78 million infants utilizing infant formula in 2014 alone. As science advances and researchers deepen their understanding of the complexity of mother's milk, developers of infant formula strive to mimic human breast milk as closely as possible. However, we now know infant formula falls short, as the majority of formulas lack probiotics – live microorganisms thought to have crucial functions in the optimal development of infants that are present in natural mother's milk. This report forecasts the adoption of probiotics in the infant formula market in the coming decade.

Coverage Area

  • Emerging Ecosystems in Agrifood and Health

Table of Contents

  • Title page
  • Executive Summary
  • Table of Contents
  • Overview
  • Landscape
  • Analysis
  • Outlook
  • References

Lead Analyst

Camilla Stice

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978